Massive Bio

Developer of an artificial intelligence-driven platform intended to connect cancer patients to biopharmaceutical clinical trials. The company offers tech-enabled services and a big data platform that addresses the clinical trial enrollment value chain by provi

Operating in health tech based in Greater New York Area, East Coast, Northeastern US, Massive Bio was founded in 2015.

Profile

Developer of an artificial intelligence-driven platform intended to connect cancer patients to biopharmaceutical clinical trials. The company offers tech-enabled services and a big data platform that addresses the clinical trial enrollment value chain by providing patient identification, pre-screening, and concierge enrollment enablement while being focused on oncology and innovative data, technology, and services, enabling patients to get an effective treatment without disrupting lives and becoming a financial hindrance.

Its activity falls under health tech; the profile below is assembled from public directory data.

Greater New York Area, East Coast, Northeastern US is where the company is located.

Directory data places it at the Series B stage.

Its team size is recorded as c_00011_00050 employees.

Public records show total funding of about $23.8M.

Website: massivebio.com